Typhim Vi™ (Sanofi Pasteur)
(typhoid vaccine)
Vaccine Type: polysaccharide vaccine
Composition: purified Vi capsular polysaccharides of Salmonella typhi (Ty2 strain) 25mcg/0.5ml
Dosage:
- indicated for active immunisation over 5 years of age
- 0.5ml per dose: im/sc one single dose
- revaccination every 3 years if continued risk of exposure
Contraindicated in:
- hypersensitivity to any component
- not to be injected intravascularly
- not indicated for <2y/o due to insufficient Ab response
- delay vaccination if acute severe febrile illness
Pregnancy: insufficient data; pregnancy is not a reason not to administer vaccine in view of seriousness of disease and in case of high risk of exposure.
Lactation: caution is advised.
Adverse reactions:
usually moderate & of short duration
local injection site reactions (pain, edema, redness)
Ref:
- promotional material, Sanofi Pasteur